AMBALALSAPharmaceuticals
Ambalal Sarabhai Enterprises Ltd — Cash Flow Statement
₹24.27
-4.23%
Ambalal Sarabhai Enterprises Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -20.33 Cr | 5.98 Cr | -14.94 Cr | -4.24 Cr | — |
| Capital Expenditure | -2.72 Cr | -2.91 Cr | -20.67 Cr | -15.71 Cr | — |
| End Cash Position | 4.89 Cr | 10.78 Cr | 10.13 Cr | 12.10 Cr | — |
| Beginning Cash Position | 10.78 Cr | 10.13 Cr | 12.10 Cr | 14.74 Cr | — |
| Changes In Cash | -5.88 Cr | 0.65 Cr | -1.97 Cr | -2.64 Cr | — |
| Financing Cash Flow | -1.53 Cr | -2.95 Cr | 9.09 Cr | -19.19 Cr | — |
| Interest Paid Cff | -4.04 Cr | -3.76 Cr | -4.65 Cr | -1.57 Cr | — |
| Net Issuance Payments Of Debt | 3.50 Cr | 1.68 Cr | 14.52 Cr | -2.02 Cr | — |
| Net Short Term Debt Issuance | 4.93 Cr | 2.97 Cr | -0.80 Cr | 0.43 Cr | — |
| Net Long Term Debt Issuance | -1.43 Cr | -1.29 Cr | 15.32 Cr | -2.45 Cr | — |
| Investing Cash Flow | 13.26 Cr | -5.30 Cr | -16.78 Cr | 5.08 Cr | — |
| Net Other Investing Changes | 0.01 Cr | — | — | — | -0.11 Cr |
| Interest Received Cfi | 2.61 Cr | 1.27 Cr | 2.44 Cr | 1.40 Cr | — |
| Dividends Received Cfi | 0.01 Cr | 0.01 Cr | 0.01 Cr | 0.01 Cr | — |
| Net Investment Purchase And Sale | 13.19 Cr | -4.17 Cr | -50000.00 | 0.03 Cr | — |
| Net PPE Purchase And Sale | -2.55 Cr | -2.45 Cr | -19.23 Cr | 3.58 Cr | — |
| Sale Of PPE | 0.17 Cr | 0.46 Cr | 1.44 Cr | 19.29 Cr | — |
| Purchase Of PPE | -2.72 Cr | -2.91 Cr | -20.67 Cr | -15.71 Cr | — |
| Operating Cash Flow | -17.62 Cr | 8.89 Cr | 5.72 Cr | 11.47 Cr | — |
| Taxes Refund Paid | -3.22 Cr | -4.00 Cr | -4.42 Cr | -3.55 Cr | — |
| Change In Working Capital | -21.43 Cr | 1.77 Cr | -4.43 Cr | -19.35 Cr | — |
| Change In Other Current Liabilities | 2.86 Cr | -3.41 Cr | 2.10 Cr | -8.87 Cr | — |
| Change In Other Current Assets | -12.79 Cr | -1.45 Cr | 1.76 Cr | -18.84 Cr | — |
| Change In Payable | 14.09 Cr | 4.51 Cr | -4.74 Cr | -0.94 Cr | — |
| Change In Inventory | -7.45 Cr | 1.23 Cr | -2.28 Cr | 0.82 Cr | — |
| Change In Receivables | -18.11 Cr | 0.64 Cr | -0.44 Cr | 10.07 Cr | — |
| Other Non Cash Items | 0.68 Cr | -2.42 Cr | -5.37 Cr | 13.12 Cr | — |
| Provisionand Write Offof Assets | -2.27 Cr | 0.60 Cr | 0.82 Cr | -0.03 Cr | — |
| Depreciation And Amortization | 4.01 Cr | 3.57 Cr | 2.76 Cr | 2.32 Cr | — |
| Depreciation | 4.01 Cr | 3.57 Cr | 2.74 Cr | 2.30 Cr | — |
| Gain Loss On Investment Securities | 0.04 Cr | -0.02 Cr | 0.27 Cr | -0.02 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 0.02 Cr | 0.01 Cr | -0.04 Cr | 0.02 Cr | — |
| Gain Loss On Sale Of PPE | 0.35 Cr | -0.03 Cr | -0.07 Cr | -29.49 Cr | — |
| Net Income From Continuing Operations | 4.83 Cr | 6.65 Cr | 15.17 Cr | 54.19 Cr | — |
| Net Other Financing Charges | — | -9000.00 | — | -15.11 Cr | — |
| Amortization Cash Flow | — | 39000.00 | 0.01 Cr | 0.01 Cr | — |
| Sale Of Investment | — | — | — | 0.03 Cr | 0.02 Cr |
| Net Business Purchase And Sale | — | — | — | — | 0.00 |
| Sale Of Business | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Ambalal Sarabhai Enterprises Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.